CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $236,518 | +16.5% | 4,213 | +35.3% | 0.09% | -16.5% |
Q3 2022 | $203,000 | -34.9% | 3,113 | -24.3% | 0.10% | -2.8% |
Q4 2021 | $312,000 | -10.1% | 4,113 | +32.5% | 0.11% | -22.1% |
Q3 2021 | $347,000 | -30.0% | 3,103 | +1.3% | 0.14% | -27.7% |
Q2 2021 | $496,000 | +33.0% | 3,063 | 0.0% | 0.19% | +24.5% |
Q1 2021 | $373,000 | -18.7% | 3,063 | +2.1% | 0.15% | -22.2% |
Q4 2020 | $459,000 | +92.9% | 3,000 | +5.3% | 0.19% | +59.0% |
Q3 2020 | $238,000 | – | 2,850 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |